June 23, 2020 / 12:32 PM / 13 days ago

BRIEF-Beyondspring Says Preclinical Research Findings Indicate Plinabulin Enhances Immuno-Radiotherapy

June 23 (Reuters) - Beyondspring Inc:

* BEYONDSPRING - NEW PRECLINICAL RESEARCH FINDINGS THAT INDICATE BEYONDSPRING’S LEAD ASSET, PLINABULIN, ENHANCES IMMUNO-RADIOTHERAPY FOR CANCER PATIENTS. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below